Negara: Inggris
Bahasa: Inggris
Sumber: VMD (Veterinary Medicines Directorate)
Milbemycin Oxime (A3 and A4), Praziquantel
Virbac
QP54AB51
Milbemycin Oxime (A3 and A4), Praziquantel
Tablet
POM-V - Prescription Only Medicine – Veterinarian
Dogs
Anthelmintic
Authorized
2014-07-15
Revised: September 2021 AN: 02228/2020 & 02229/2020 Page 1 of 7 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Milpro 2.5 mg/25 mg film-coated tablets for small dogs and puppies 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: ACTIVE SUBSTANCES: Milbemycin oxime 2.5 mg Praziquantel 25 mg EXCIPIENTS: For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Film-coated tablet. Oval shaped, beige to pale brown, meat flavoured tablets with a score on both sides. The tablets can be divided into halves. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs (small dogs and puppies). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES In dogs: treatment of mixed infections by adult cestodes (tapeworms) and nematodes (roundworms) of the following species: Cestodes: _Dipylidium caninum,_ _Taenia _spp., _Echinococcus _spp., _Mesocestoides _spp. Nematodes: _Ancylostoma caninum,_ _Toxocara canis,_ _Toxascaris leonina,_ _Trichuris vulpis,_ _Thelazia _ _callipaeda_ (see specific treatment schedules under section 4.9 “Amounts to be administered and administration route”), _Crenosoma vulpis_ (Reduction of the level of infection), _Angiostrongylus vasorum_ (Reduction of the level of infection by immature adult (L5) and adult parasite stages; see specific treatment and disease prevention schedules under section “4.9 Amounts to be administered and administration route”). The product can also be used in the prevention of heartworm disease (_Dirofilaria _ _immitis_), if concomitant treatment against cestodes is indicated. Revised: September 2021 AN: 02228/2020 & 02229/2020 Page 2 of 7 4.3 CONTRAINDICATIONS Do not use in puppies of less than 2 weeks of age and/or weighing less than 0.5 kg. Do not use in cases of hypersensitivity to the active substances or to any of the excipients. See also point "Special precautions for use". 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES In order to develop an effective worm control programme local epidemiological information and the Baca dokumen lengkapnya